AbbVie to acquire Allergan in “transformative move”

Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...

Novartis acquires IFM Tre

Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...

GHO Capital acquires Sterling Pharma Solutions

European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...

Healthtech M&A and IPO Activity

The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...

DoseCare acquires Biodose

DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...

UK pharma pressing ahead with M&As in 2019

The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...

Sanofi and Denali join forces on inflammatory disease drugs

Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...

AstraZeneca divests rights for Nexium and Vimovo to Grünenthal

AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...

Mundipharma acquires biosimilars development company

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company, Cinfa...

BioIVT acquires CTLS a UK blood donor facility

BioIVT acquires Clinical Trials Laboratory Services (CTLS), a donor centre and laboratory based in London, UK. BioIVT, is a provider of research models and...

Latest articles

hands shaking in front of a contract being signed by a man and a woman to show Servier and UCL collaborate on immune-inflammatory disease treatments

Servier and UCL collaborate on immune-inflammatory disease treatments

Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...
Man and woman shaking hands to show Forendo and Novartis partner on novel chronic liver disease treatments

Forendo and Novartis partner on novel chronic liver disease treatments

Forendo and Novartis are to partner on novel chronic liver disease treatments. Forendo Pharma, a clinical stage drug development company focusing on novel treatments...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...

Popular articles

Doctor and patient: HIV and AIDS around the world

Living well with HIV and AIDS around the world

1st December is World AIDS Day which raises awareness of HIV and AIDS around the world. There have been huge leaps in the treatment...
Graphic of Scotland with the Scottish flag over the top to show AstraZeneca and MSD's Lynparza™ now available in Scotland

AstraZeneca and MSD’s Lynparza™ now available in Scotland

AstraZeneca and MSD's Lynparza™ is now available in Scotland as the companies announce that olaparib monotherapy is now accepted for use by the Scottish...
Scientist at desk: LifeArc advancing research and science

How are LifeArc collaborating to advance research and science for patient benefit?

Melanie Lee CBE is Chief Executive of LifeArc, a self-funded medical research charity that is working in collaboration to translate early science for patient...
Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial

Kite announces new Yescarta® data from pivotal ZUMA-1 trial. The new data from the pivotal ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) showed that approximately...
Business people merging: 20 clinical commissioning groups merge

Merging CCGs to align commissioning

Julie Das-Thompson, Head of Policy and Delivery at NHS Clinical Commissioners, researches how 2020 will see the merging of at least 20 clinical commissioning...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription